SEC Form 4 · accession 0001140361-17-029733
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brett Sandercock
Officer — Chief Financial Officer
Period of report
Aug 1, 2017
Accepted (ET)
Aug 1, 2017 · 9:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Aug 1, 2017 | S | 1,250 | $77.49 | D | 59,258 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction was conducted under a Rule10b5-1 Plan.